Cargando…

Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction

Leucine Rich Repeat Kinase 2 (LRRK2) is the most commonly mutated gene in familial Parkinson’s disease (PD)(1) and is also linked to its idiopathic form(2). LRRK2 is proposed to function in membrane trafficking(3) and co-localizes with microtubules(4). Despite LRRK2’s fundamental importance for unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deniston, CK, Salogiannis, J, Mathea, S, Snead, DM, Lahiri, I, Matyszewski, M, Donosa, O, Watanabe, R, Böhning, J, Shiau, AK, Knapp, S, Villa, E, Reck-Peterson, SL, Leschziner, AE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726071/ https://www.ncbi.nlm.nih.gov/pubmed/32814344 http://dx.doi.org/10.1038/s41586-020-2673-2

Ejemplares similares

Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
por: Snead, David M., et al.
Publicado: (2022)

Structural Biology of LRRK2 and its Interaction with Microtubules
por: Leschziner, Andres E., et al.
Publicado: (2021)

Structure of LRRK1 and mechanisms of autoinhibition and activation
por: Reimer, Janice M., et al.
Publicado: (2023)

Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures
por: Sanz Murillo, Marta, et al.
Publicado: (2023)

Lis1 Acts as a “Clutch” between the ATPase and Microtubule-Binding Domains of the Dynein Motor
por: Huang, Julie, et al.
Publicado: (2012)

Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms
por: Malik, Asad U., et al.
Publicado: (2021)

Peroxisomes move by hitchhiking on early endosomes using the novel linker protein PxdA
por: Salogiannis, John, et al.
Publicado: (2016)

Kinase Domain Is a Dynamic Hub for Driving LRRK2 Allostery
por: Taylor, Susan S., et al.
Publicado: (2020)

Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding
por: Kalogeropulou, Alexia F., et al.
Publicado: (2022)

Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2
por: Schmidt, Sven H., et al.
Publicado: (2021)

PxdA interacts with the DipA phosphatase to regulate peroxisome hitchhiking on early endosomes
por: Salogiannis, John, et al.
Publicado: (2021)

LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains
por: Weng, Jui-Hung, et al.
Publicado: (2022)

Reconstitution of dynein transport to the microtubule plus end by kinesin
por: Roberts, Anthony J, et al.
Publicado: (2014)

Structural basis for cytoplasmic dynein-1 regulation by Lis1
por: Gillies, John P, et al.
Publicado: (2022)

Optimizing microtubule arrangements for rapid cargo capture
por: Mogre, Saurabh S., et al.
Publicado: (2021)

PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the COR(B) GTPase domain
por: Malik, Asad U., et al.
Publicado: (2022)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
por: Singh, Ranjan K., et al.
Publicado: (2022)

Structures of human dynein in complex with the lissencephaly 1 protein, LIS1
por: Reimer, Janice M, et al.
Publicado: (2023)

Expression Analysis of Lrrk1, Lrrk2 and Lrrk2 Splice Variants in Mice
por: Giesert, Florian, et al.
Publicado: (2013)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

LRRK2 and the Endolysosomal System in Parkinson’s Disease
por: Erb, Madalynn L., et al.
Publicado: (2020)

LRRK2 at the Crossroad of Aging and Parkinson’s Disease
por: Hur, Eun-Mi, et al.
Publicado: (2021)

Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020)

Modeling Parkinson’s disease in LRRK2 rodents
por: Domenicale, Chiara, et al.
Publicado: (2023)

Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
por: Chen, Kang, et al.
Publicado: (2023)

Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson’s disease
por: Fava, Vinicius M., et al.
Publicado: (2019)

Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
por: Gonzalez-Hunt, C. P., et al.
Publicado: (2020)

Lis1 relieves cytoplasmic dynein-1 autoinhibition by acting as a molecular wedge
por: Karasmanis, Eva P., et al.
Publicado: (2023)

Dynamic and redundant regulation of LRRK2 and LRRK1 expression
por: Biskup, Saskia, et al.
Publicado: (2007)

LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)

Metabolomic Profiling in LRRK2-Related Parkinson's Disease
por: Johansen, Krisztina K., et al.
Publicado: (2009)

Genetic Variants of LRRK2 in Taiwanese Parkinson’s Disease
por: Wu, Yih-Ru, et al.
Publicado: (2013)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
por: Bliederhaeuser, Corinna, et al.
Publicado: (2016)

Roco Proteins and the Parkinson’s Disease-Associated LRRK2
por: Liao, Jingling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_611tqv9nr37h7knf513oq7b4lm